StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research note published on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.

Data from the Centers for Disease Control and Prevention show there were about 107,000 drug overdose deaths in the United States in 2023. Of those, about 75%, or 81,000, involved opioids.

The recently published book, “Opioids 360: A Multidisciplinary Examination of an American Tragedy,” was edited by MU Criminal Justice Professors Sarah and Eric See and has chapters by 12 ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally ... looking to expand the label of their products to combat the opioid crisis. Early clinical work has shown that GLP-1RAs are ...

Co-prescribed stimulants, opioids linked to higher opioid doses Study analyzes millions of U.S. prescriptions over 10 years Date: February 21, 2025 Source: Ohio State University Summary: The ...

There are GLP-1 receptors in the brain’s mesolimbic system, which is inextricably linked to motivation and reward. This has piqued the interest of drug developers looking to expand the label of their ...

Stewart Clark, PhD, associate professor of pharmacology and toxicology, is principal investigator on a two-year, $420,000 grant titled “Preclinical Trial: Targeting the Neuropeptide S Receptor to Curb ...

The treatment of severe pain with opioids has thus far been limited by their unwanted central side effects. Recent research promises new approaches, including opioid analgesics acting outside the ...

As an opioid itself, buprenorphine excites opioid receptors, preventing withdrawal symptoms. But unlike with other opioids, including methadone, which is also used to treat opioid addiction ...

Opioids counter pain through receptors in the spinal cord to block this pain stimulus but they also trigger receptors in the brain to create euphoria and an addiction potential. This new drug works ...